Helix Acquisition and BridgeBio Oncology receive SEC approval for merger
Go back to Helix Acquisition and BridgeBio Oncology receive SEC approval for merger| (NASDAQ: BBIO) | Delayed: 69.36 +0.73 (1.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.63 | 52 Week High | $ | |||
| Open | $69.25 | 52 Week Low | $ | |||
| Day High | $70.77 | P/E | N/A | |||
| Day Low | $68.94 | EPS | $ | |||
| Volume | 4,190,473 | |||||
| (NASDAQ: HLXB) | Delayed: 9.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.90 | 52 Week High | $ | |||
| Open | $9.90 | 52 Week Low | $ | |||
| Day High | $9.90 | P/E | N/A | |||
| Day Low | $9.90 | EPS | $ | |||
| Volume | 51,325 | |||||

